USA Financial Formulas’s Globe Life GL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-6
Closed -$835 461
2026
Q1
$835 Sell
6
-600
-99% -$84.7K ﹤0.01% 347
2025
Q4
$84.8K Sell
606
-5,237
-90% -$709K 0.02% 211
2025
Q3
$835K Sell
5,843
-1,146
-16% -$155K 0.15% 52
2025
Q2
$869K Sell
6,989
-1,945
-22% -$236K 0.15% 67
2025
Q1
$1.18M Buy
+8,934
New +$1.09M 0.19% 40
2024
Q2
Sell
-8,242
Closed -$959K 332
2024
Q1
$959K Buy
+8,242
New +$1.01M 0.16% 69
2023
Q4
Sell
-6,917
Closed -$752K 423
2023
Q3
$752K Hold
6,917
1.12% 23
2023
Q2
$758K Sell
6,917
-1,742
-20% -$187K 1.16% 30
2023
Q1
$953K Buy
+8,659
New +$1.02M 1.54% 20
2018
Q1
Sell
-5,501
Closed -$499K 348
2017
Q4
$499K Buy
+5,501
New +$472K 0.12% 147
2016
Q3
Sell
-7,636
Closed -$472K 259
2016
Q2
$472K Buy
+7,636
New +$446K 0.13% 127

Other funds holding GL

USA Financial Formulas's GL Position: Q2 2026 in Review

USA Financial Formulas sold out of Globe Life (GL) in Q2 2026, closing a stake of 6 shares — an estimated $835 sold.

USA Financial Formulas first reported a position in GL in Q2 2016 and held it in 11 quarters. The position peaked at $1.18M in Q1 2025. 696 funds tracked by Wall St. Rank hold GL as of Q2 2026.

  • USA Financial Formulas reported no remaining Globe Life position as of Q2 2026 after selling out during the quarter.
  • USA Financial Formulas sold 6 Globe Life shares in Q2 2026, an estimated $835.
  • USA Financial Formulas first reported a position in Globe Life in Q2 2016 and held it in 11 quarters.
  • USA Financial Formulas's Globe Life position peaked at $1.18M in Q1 2025.
  • 696 funds tracked by Wall St. Rank held Globe Life as of Q2 2026.

Based on USA Financial Formulas's 13F filing for Q2 2026, filed 4 Aug 2026.